This is a surgery to help babies with certain heart problems get enough oxygen. It creates a new pathway for blood to flow from the body's main artery (the aorta) to the lungs. This helps the baby's lungs work better and get more oxygen, making them feel less blue.
Every report comes from a Lived member, sent anonymously.
Have you had Blalock-Taussig Shunt for Pulmonary Atresia?
A Blalock-Taussig shunt, or BT shunt, is heart surgery that gives blood a second route to the lungs. A surgeon sews a small synthetic tube, only a few millimeters wide, between an artery that carries blood to the body (usually the subclavian artery, which supplies the arm) and the pulmonary artery, which carries blood to the lungs. More blood passing through the lungs means more oxygen reaches the body. The operation was first performed in 1944 and is now often called the Blalock-Taussig-Thomas shunt, recognizing Vivien Thomas, whose technical work made it possible. It is done mostly in newborns, usually in the first weeks of life, whose heart defects block or shrink the normal path to the lungs. Examples include pulmonary atresia, tricuspid atresia, some forms of tetralogy of Fallot and some single-ventricle defects (hearts with only one working pumping chamber). In hypoplastic left heart syndrome, a similar shunt is built as one part of a larger first operation, the Norwood procedure; this page describes the stand-alone shunt. Before birth, and briefly afterward, these babies rely on a small fetal blood vessel called the ductus arteriosus to carry blood to the lungs. When it closes, oxygen levels can fall dangerously, and the shunt takes over its job. A BT shunt does not fix the defect. It is a temporary bridge: the tube cannot grow with the child, so a later operation replaces it, such as a Glenn procedure for single-ventricle hearts (often between about 3 and 6 months of age) or a complete repair for some other defects. In some babies, a ductal stent is an alternative. A cardiologist guides a small mesh tube through a blood vessel by catheter to hold the ductus open, avoiding a chest incision. Studies comparing the two, all observational, suggest stents bring shorter hospital stays and fewer procedural complications but more unplanned repeat procedures. The choice depends on the baby's anatomy and the center's experience.
Most babies who need a BT shunt are already in a newborn or cardiac intensive care unit. Many receive prostaglandin, a medicine given through an IV (a thin tube in a vein) that keeps the ductus arteriosus open so blood keeps reaching the lungs until surgery. Some also need a breathing machine, medicines that support the heart, or diuretics to remove extra fluid. The team aims to have the baby as stable as possible before the operation. An echocardiogram, an ultrasound of the heart, maps the defect and the size of the pulmonary arteries, which helps the surgeon plan the shunt. Some babies also need a heart MRI (magnetic resonance imaging, a detailed scan that uses magnets rather than X-rays) or cardiac catheterization, in which a thin tube is guided through a blood vessel to the heart to measure pressures and take pictures. The surgical and anesthesia teams explain the plan, the expected recovery and the risks before parents give consent.
The operation is done under general anesthesia, so the baby is fully asleep. The surgeon reaches the arteries either through the side of the chest between the ribs (a thoracotomy) or through the breastbone (a sternotomy). The tube graft is cut to length, and one end is sewn to the systemic artery and the other to the pulmonary artery. Its width is chosen by the baby's size, because the width largely sets how much blood flows to the lungs. Many shunts are placed without a heart-lung bypass machine, but one is used when the surgical plan calls for it. Surgery usually takes about two to four hours. Afterward the baby returns to the cardiac intensive care unit with a breathing tube, lines to monitor blood pressure and give medicines, chest tubes that drain fluid from around the lungs, and a urinary catheter.
Most babies come off the breathing machine within about a day, and chest tubes usually come out soon after. The first days are when the shunt is most likely to clot, so the team starts heparin, a blood thinner given by IV, shortly after surgery, then switches to aspirin once the baby is feeding well. Doctors adjust breathing support, fluids and medicines to balance blood flow between the lungs and the body. A typical hospital stay is about one to two weeks, though it varies with the baby's heart defect and recovery. Even when the shunt works well, a baby usually stays somewhat blue. The usual target is an oxygen saturation (the share of red blood cells carrying oxygen, measured with a clip-on sensor called a pulse oximeter) of roughly 75 to 85 percent. That range gives the body enough oxygen without flooding the lungs with blood, and it improves after the next surgery. At home, aspirin is given every day until the next heart surgery to help keep the shunt from clotting; do not stop it, or give other fever or pain medicines, without checking with the team. Many babies also take a diuretic or other heart medicines. Many centers run home monitoring programs in which families check oxygen levels with a pulse oximeter and weigh the baby on a schedule, and the team follows feeding and growth closely. Dehydration makes the shunt more likely to clot, so keeping the baby fed and hydrated matters. Call the cardiology team right away if the oxygen reading falls below the level the team gave you, or if the baby has repeated vomiting or diarrhea, a fever, poor feeding, weight loss or breathing that is harder than usual. A sudden turn much bluer or gray, struggling to breathe, or a baby who is limp or hard to wake can mean the shunt is blocked: call 911.
A BT shunt is major surgery on a very small and often fragile baby, and the risks are real. In a large US registry of newborns who had the operation between 2002 and 2009, about 7 percent died before leaving the hospital. Risk was higher in babies weighing less than 3 kilograms (about 6.6 pounds), those who needed a breathing machine before surgery, and those with single-ventricle hearts or pulmonary atresia with an intact ventricular septum (no hole in the wall between the lower pumping chambers). Results vary by center and era, so it is reasonable to ask a team about its own outcomes. The most important shunt-specific problems are clotting and narrowing of the tube, which cut off blood flow to the lungs and are closely tied to death. Aspirin appears to lower this risk but does not remove it, and some babies need a shunt revision or a catheter procedure. The opposite problem, too much blood flow to the lungs (overcirculation), can strain the heart and cause fluid in the lungs; it is managed with medicines and sometimes a procedure. Other complications after surgery include infections such as pneumonia, a slow heart rate and heart failure. The months at home between the shunt and the next operation carry their own risk. A sudden fall in shunt flow, and ordinary childhood illnesses that cause dehydration or low oxygen, have both been linked to deaths during this stage. That is why home monitoring and a low threshold for calling the team matter.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Blalock-Taussig Shunt, what to expect, or ask the community a question.